HomeCompareHOLX vs PAA

HOLX vs PAA: Dividend Comparison 2026

HOLX yields 2.65% · PAA yields 6.93%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PAA wins by $6.69M in total portfolio value
10 years
HOLX
HOLX
● Live price
2.65%
Share price
$75.55
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.6K
Annual income
$314.03
Full HOLX calculator →
PAA
PAA
● Live price
6.93%
Share price
$22.47
Annual div
$1.56
5Y div CAGR
57%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.71M
Annual income
$5,114,230.35
Full PAA calculator →

Portfolio growth — HOLX vs PAA

📍 PAA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHOLXPAA
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HOLX + PAA cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HOLX pays
PAA pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HOLX
Annual income on $10K today (after 15% tax)
$225.02/yr
After 10yr DRIP, annual income (after tax)
$266.93/yr
PAA
Annual income on $10K today (after 15% tax)
$589.17/yr
After 10yr DRIP, annual income (after tax)
$4,347,095.80/yr
At 15% tax rate, PAA beats the other by $4,346,828.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HOLX + PAA for your $10,000?

HOLX: 50%PAA: 50%
100% PAA50/50100% HOLX
Portfolio after 10yr
$3.37M
Annual income
$2,557,272.19/yr
Blended yield
75.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PAA right now

HOLX
Analyst Ratings
18
Buy
23
Hold
1
Sell
Consensus: Hold
Price Target
$77.80
+3.0% upside vs current
Range: $76.00 — $79.00
Altman Z
4.2
Piotroski
7/9
PAA
Analyst Ratings
1
Strong
23
Buy
16
Hold
2
Sell
Consensus: Buy
Price Target
$21.83
-2.8% upside vs current
Range: $17.00 — $25.00
Altman Z
2.3
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HOLX buys
0
PAA buys
0
No recent congressional trades found for HOLX or PAA in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHOLXPAA
Forward yield2.65%6.93%
Annual dividend / share$2.00$1.56
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%57%
Portfolio after 10y$23.6K$6.71M
Annual income after 10y$314.03$5,114,230.35
Total dividends collected$2.9K$6.54M
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusHoldBuy
Analyst price target$77.80$21.83

Year-by-year: HOLX vs PAA ($10,000, DRIP)

YearHOLX PortfolioHOLX Income/yrPAA PortfolioPAA Income/yrGap
1← crossover$10,965$264.73$11,788$1,088.24$823.00PAA
2$12,004$271.27$14,496$1,882.30$2.5KPAA
3$13,121$277.55$18,907$3,396.22$5.8KPAA
4$14,323$283.54$26,730$6,499.60$12.4KPAA
5$15,615$289.27$42,084$13,482.87$26.5KPAA
6$17,003$294.73$76,177$31,147.09$59.2KPAA
7$18,493$299.93$164,235$82,725.90$145.7KPAA
8$20,093$304.87$437,430$261,698.43$417.3KPAA
9$21,809$309.57$1,490,777$1,022,727.50$1.47MPAA
10$23,649$314.03$6,709,362$5,114,230.35$6.69MPAA

HOLX vs PAA: Complete Analysis 2026

HOLXHealthcare

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Full HOLX Calculator →

PAAStock

Plains All American Pipeline, L.P., through its subsidiaries, engages in the pipeline transportation, terminalling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates in two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and at times on barges or railcars. This segment provides terminalling, storage, and other facilities-related services, as well as merchant activities. As of December 31, 2021, this segment owned and leased 18,300 miles of active crude oil transportation pipelines and gathering systems, as well as an additional 110 miles of pipelines that supports crude oil storage and terminalling facilities; 74 million barrels of commercial crude oil storage capacity; 38 million barrels of active, above-ground tank capacity; four marine facilities; a condensate processing facility; seven crude oil rail terminals and 2,100 crude oil railcars; and 640 trucks and 1,275 trailers. The Natural Gas Liquids segment engages in the natural gas processing, NGL fractionation, storage, transportation, and terminalling activities. As of December 31, 2021, this segment owned and operated four natural gas processing plants; nine fractionation plants; 28 million barrels of NGL storage capacity; approximately 1,620 miles of active NGL transportation pipelines, as well as an additional 55 miles of pipeline that supports NGL storage facilities; 16 NGL rail terminals and approximately 3,900 NGL rail cars; and approximately 220 trailers. The company was founded in 1981 and is headquartered in Houston, Texas. Plains All American Pipeline, L.P. operates as a subsidiary of Plains GP Holdings, L.P.

Full PAA Calculator →
📬

Get this HOLX vs PAA comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HOLX vs SCHDHOLX vs JEPIHOLX vs OHOLX vs KOHOLX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.